-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Achilles Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2019 to Q2 2024.
- Achilles Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 40.4M shares, a 1.14% increase year-over-year.
- Achilles Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 40M shares, a 2.13% increase from 2022.
- Achilles Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 39.1M shares, a 36.6% increase from 2021.
- Achilles Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 28.7M shares, a 2588% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)